Nels Thorsteinson

Nels Thorsteinson

Auto-generated profile, based on publicly available information

Nels Thorsteinson

Chemical Computing Group

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 July 2011 in Proteins: Structure, Function, and Bioinformatics
Verified
Journal Article
Closed access
PDF file
JAJuan Almagro
Juan Almagro
MBMary Pat Beavers
Mary Pat Beavers
FHFrancisco Hernandez‐Guzman
Francisco Hernandez‐Guzman
JMJohannes Maier
Johannes Maier
JSJodi Shaulsky
Jodi Shaulsky
GGGary L. Gilliland
Gary L. Gilliland

1 January 2021 in mAbs
Verified
Journal Article
Open access
NTNels Thorsteinson
Nels Thorsteinson
JGJohn R. Gunn
John R. Gunn
KKKenneth Kelly
Kenneth Kelly
WLWill Long
Will Long
PLPaul Labute
Paul Labute
The effect of hydrophobicity on antibody aggregation is well understood, and it has been shown that charge calculations can be useful for high-concentration viscosity and pharmacokinetic (PK) clearance predictions. In this work, structure-based charge descriptors are evaluated for their predictive performance on recently published antibody pI, viscosity, and clearance data. From this, we devised four rules for therapeutic antibody profiling which address developability issues arising from hydrophobicity and charged-based solution behavior, PK, and the ability to enrich for those that are approved by the U.S. Food and Drug Administration. Differences in strategy for optimizing the solution behavior of human IgG1 antibodies versus the IgG2 and IgG4 isotypes and the impact of pH alterations in formulation are discussed.

11 March 2008 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
ACArtem Cherkasov
Artem Cherkasov
FBFuqiang Ban
Fuqiang Ban
Osvaldo Andrade Santos-FilhoOsvaldo Andrade Santos-Filho
Osvaldo Andrade Santos-Filho
NTNels Thorsteinson
Nels Thorsteinson
MFMagid Fallahi
Magid Fallahi
GHGeoffrey L. Hammond
Geoffrey L. Hammond

15 August 2018 in mAbs
Verified
Journal Article
Open access
AJArif Jetha
Arif Jetha
NTNels Thorsteinson
Nels Thorsteinson
YJYazen Jmeian
Yazen Jmeian
AJAjitha Jeganathan
Ajitha Jeganathan
PGPatricia Giblin
Patricia Giblin
JFJohan Fransson
Johan Fransson
Monoclonal antibody (mAb) candidates from high-throughput screening or binding affinity optimization often contain mutations leading to liabilities for further development of the antibody, such as aggregation-prone regions and lack of solubility. In this work, we optimized a candidate integrin α11-binding mAb for developability using molecular modeling, rational design, and hydrophobic interaction chromatography (HIC). A homology model of the parental mAb Fv region was built, and this revealed hydrophobic patches on the surface of the complementarity-determining region loops. A series of 97 variants of the residues primarily responsible for the hydrophobic patches were expressed and their HIC retention times (RT) were measured. As intended, many of the computationally designed variants reduced the HIC RT compared to the parental mAb, and mutating residues that contributed most to hydrophobic patches had the greatest effect on HIC RT. A retrospective analysis was then performed where 3-dimentional protein property descriptors were evaluated for their ability to predict HIC RT using the current series of mAbs. The same descriptors were used to train a simple multi-parameter protein quantitative structure-property relationship model on this data, producing an improved correlation. We also extended this analysis to recently published HIC data for 137 clinical mAb candidates as well as 31 adnectin variants, and found that the surface area of hydrophobic patches averaged over a molecular dynamics sample consistently correlated to the experimental data across a diverse set of biotherapeutics.

3 April 2023 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
HAHannes Ausserwöger
Hannes Ausserwöger
GKGeorg Krainer
Georg Krainer
TWTimothy J. Welsh
Timothy J. Welsh
NTNels Thorsteinson
Nels Thorsteinson
ECElla de Csilléry
Ella de Csilléry
Tuomas KnowlesTuomas Knowles
Tuomas Knowles
Nonspecific interactions are a key challenge in the successful development of therapeutic antibodies. The tendency for nonspecific binding of antibodies is often difficult to reduce by rational design, and instead, it is necessary to rely on comprehensive screening campaigns. To address this issue, we performed a systematic analysis of the impact of surface patch properties on antibody nonspecificity using a designer antibody library as a model system and single-stranded DNA as a nonspecificity ligand. Using an in-solution microfluidic approach, we find that the antibodies tested bind to single-stranded DNA with affinities as high as K D = 1 µM. We show that DNA binding is driven primarily by a hydrophobic patch in the complementarity-determining regions. By quantifying the surface patches across the library, the nonspecific binding affinity is shown to correlate with a trade-off between the hydrophobic and total charged patch areas. Moreover, we show that a change in formulation conditions at low ionic strengths leads to DNA-induced antibody phase separation as a manifestation of nonspecific binding at low micromolar antibody concentrations. We highlight that phase separation is driven by a cooperative electrostatic network assembly mechanism of antibodies with DNA, which correlates with a balance between positive and negative charged patches. Importantly, our study demonstrates that both nonspecific binding and phase separation are controlled by the size of the surface patches. Taken together, these findings highlight the importance of surface patches and their role in conferring antibody nonspecificity and its macroscopic manifestation in phase separation.

1 January 2009 in Toxicology and Applied Pharmacology
Verified
Journal Article
Closed access
NTNels Thorsteinson
Nels Thorsteinson
FBFuqiang Ban
Fuqiang Ban
Osvaldo Andrade Santos-FilhoOsvaldo Andrade Santos-Filho
Osvaldo Andrade Santos-Filho
STSeyed M.H. Tabaei
Seyed M.H. Tabaei
SMSolange Miguel-Queralt
Solange Miguel-Queralt
GHGeoffrey L. Hammond
Geoffrey L. Hammond